UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CONTROLLED CLINICAL TRIAL OF COMPLETE OPEN SURGICAL DRAINAGE AND OF PREDNISOLONE IN TREATMENT OF TUBERCULOUS PERICARDIAL EFFUSION IN TRANSKEI

The Lancet (British edition), 1988-10, Vol.332 (8614), p.759-764

1988

Volltextzugriff (PDF)

CONTROLLED TRIAL OF PREDNISOLONE AS ADJUVANT IN TREATMENT OF TUBERCULOUS CONSTRICTIVE PERICARDITIS IN TRANSKEI

The Lancet (British edition), 1987-12, Vol.330 (8573), p.1418-1422

1987

Volltextzugriff (PDF)

Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up

QJM : An International Journal of Medicine, 2004-08, Vol.97 (8), p.525-535

2004

Volltextzugriff (PDF)

Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial

European journal of cancer (1990), 1997-10, Vol.33 (11), p.1752-1758

1997

Volltextzugriff (PDF)

Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience

European journal of cancer (1990), 1997, Vol.33 (1), p.20-28

1997

Volltextzugriff (PDF)

Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status

Clinical oncology (Royal College of Radiologists (Great Britain)), 1996, Vol.8 (3), p.167-175

1996

Volltextzugriff (PDF)

How reliable are the conclusions from randomised trials on palliation?: An example from the MRC/BTS LU 17 randomised trial

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.166-166

2000

Volltextzugriff (PDF)

Radiation myelopathy: Estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 1996, Vol.8 (3), p.176-181

1996

Volltextzugriff (PDF)

A comparison of patients' and doctors' perception of symptom prevention: Results from a randomised trial of supportive treatment in advanced non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.157-157

2000

Volltextzugriff (PDF)

Radiotherapy for Inoperable Lung Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2001-04, Vol.13 (2), p.86-87

2001

Volltextzugriff (PDF)

Thirty years of medical research council randomized trials in solid tumours

Clinical oncology (Royal College of Radiologists (Great Britain)), 1997, Vol.9 (2), p.100-114

1997

Volltextzugriff (PDF)

Survey of the administration of quality of life (QL) questionnaires in three multicentre randomised trials in cancer

European journal of cancer (1990), 1998-01, Vol.34 (1), p.49-57

1998

Volltextzugriff (PDF)

Treatment of Endotracheal or Endobronchial Obstruction by Non-Small Cell Lung Cancer: Lack of Patients in an MRC Randomized Trial Leaves Key Questions Unanswered

Clinical oncology (Royal College of Radiologists (Great Britain)), 1999-06, Vol.11 (3), p.179-183

1999

Volltextzugriff (PDF)

The role of pyrazinamide in primary chemotherapy for pulmonary tuberculosis

Tubercle, 1984-03, Vol.65 (1), p.1-4

Girling, D.J.

1984

Volltextzugriff (PDF)

Immediate versus delayed thoracic radiotherapy (TRT) in patients with unresectable, locally advanced non-small cell lung cancer (NSCLC) and minimal symptoms: Results of an MRC/BTS randomised trial

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.164-164

2000

Volltextzugriff (PDF)

25 Survey on the treatment of non-small cell lung cancer (NSCLC) in England and Wales

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.9-9

1997

Volltextzugriff (PDF)

Randomized trials with quality of life endpoints : Are doctor's ratings of patients'physical symptoms interchangeable with patients'self-ratings ?

Quality of life research, 1997, Vol.6 (3), p.225-236

1997

Volltextzugriff (PDF)

Treatment-related deaths in small cell lung cancer trials: can patients at risk be identified?

Lung cancer (Amsterdam, Netherlands), 1994-09, Vol.11 (3), p.259-274

1994

Volltextzugriff (PDF)

Carbon dioxide laser bronchoscopy

Respiratory medicine, 1995-05, Vol.89 (5), p.394-395

1995

Volltextzugriff (PDF)

Increasing the dose intensity of chemotherapy by means of granulocyte-colony stimulating factor (G-CSF) support in the treatment of small cell lung cancer (SCLC)

European journal of cancer (1990), 1996-06, Vol.32 (7), p.1263-1263

1996

Volltextzugriff (PDF)

The feasibility of using glycosylated recombinant human granulocyte colonystimulating factor (G-CSF) to increase the planned dose intensity of doxorubicin; cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer

European journal of cancer (1990), 1995, Vol.31 (2), p.152-156

1995

Volltextzugriff (PDF)

19 First results of a randomised trial of dose intensification (DI) with G-CSF in small cell lung cancer (SCLC)

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.7-8

1997

Volltextzugriff (PDF)

42 Updated results of a randomised trial confirm that oral etoposide alone is inadequate palliative chemotherapy (CT) for small cell lung cancer (SCLC)

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.14-14

1997

Volltextzugriff (PDF)

Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC)

Clinical oncology (Royal College of Radiologists (Great Britain)), 1995, Vol.7 (5), p.293-299

1995

Volltextzugriff (PDF)

The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis

Tubercle and lung disease, 1992-02, Vol.73 (1), p.33-38

1992

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(17)
Biological And Medical Sciences
(14)
Medical Sciences
(13)
Humans
(12)
Respiratory System
(8)
Oncology
(6)
Tuberculosis, Pulmonary - Drug Therapy
(6)
Adult
(5)
Quality Of Life
(5)
Chemotherapy
(4)
Female
(4)
Lung Cancer
(4)
Male
(4)
Pharmacology. Drug Treatments
(4)
Pyrazinamide - Adverse Effects
(4)
Radiotherapy
(4)
Adolescent
(3)
Diseases Of The Respiratory System
(3)
Drug Administration Schedule
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Tubercle
(9)
Clinical Oncology
(7)
Lung Cancer
(7)
European Journal Of Cancer
(5)
The Lancet
(5)
Respiratory Medicine
(2)
British Journal Of Cancer
(1)
Drugs
(1)
Ecotoxicology And Environmental Safety
(1)
Journal Of Molecular Structure
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CONTROLLED CLINICAL TRIAL OF COMPLETE OPEN SURGICAL DRAINAGE AND OF PREDNISOLONE IN TREATMENT OF TUBERCULOUS PERICARDIAL EFFUSION IN TRANSKEI

CONTROLLED TRIAL OF PREDNISOLONE AS ADJUVANT IN TREATMENT OF TUBERCULOUS CONSTRICTIVE PERICARDITIS IN TRANSKEI

Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up

Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial

Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience

Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status

How reliable are the conclusions from randomised trials on palliation?: An example from the MRC/BTS LU 17 randomised trial

Radiation myelopathy: Estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer

A comparison of patients' and doctors' perception of symptom prevention: Results from a randomised trial of supportive treatment in advanced non-small cell lung cancer (NSCLC)

Radiotherapy for Inoperable Lung Cancer

Thirty years of medical research council randomized trials in solid tumours

Survey of the administration of quality of life (QL) questionnaires in three multicentre randomised trials in cancer

Treatment of Endotracheal or Endobronchial Obstruction by Non-Small Cell Lung Cancer: Lack of Patients in an MRC Randomized Trial Leaves Key Questions Unanswered

The role of pyrazinamide in primary chemotherapy for pulmonary tuberculosis

Immediate versus delayed thoracic radiotherapy (TRT) in patients with unresectable, locally advanced non-small cell lung cancer (NSCLC) and minimal symptoms: Results of an MRC/BTS randomised trial

25 Survey on the treatment of non-small cell lung cancer (NSCLC) in England and Wales

Randomized trials with quality of life endpoints : Are doctor's ratings of patients'physical symptoms interchangeable with patients'self-ratings ?

Treatment-related deaths in small cell lung cancer trials: can patients at risk be identified?

Carbon dioxide laser bronchoscopy

Increasing the dose intensity of chemotherapy by means of granulocyte-colony stimulating factor (G-CSF) support in the treatment of small cell lung cancer (SCLC)

The feasibility of using glycosylated recombinant human granulocyte colonystimulating factor (G-CSF) to increase the planned dose intensity of doxorubicin; cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer

19 First results of a randomised trial of dose intensification (DI) with G-CSF in small cell lung cancer (SCLC)

42 Updated results of a randomised trial confirm that oral etoposide alone is inadequate palliative chemotherapy (CT) for small cell lung cancer (SCLC)

Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC)

The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis

Suchergebnisse filtern